The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer

Gynecologic Oncology

Volumn 124, Issue 2, 2012, Pages 185-191

  Manchanda, Ranjit ^a   Drapkin, Ronny ^b   Jacobs, Ian ^a,c   Menon, Usha ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CARBOPLATIN; DOCETAXEL; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ASCITES FLUID CYTOLOGY; BILATERAL SALPINGOOOPHORECTOMY; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; CARCINOMA IN SITU; CLINICAL PROTOCOL; FAMILIAL OVARIAN CANCER; FIMBRIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; OMENTECTOMY; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK REDUCTION; SALPINGOOOPHORECTOMY; TOTAL ABDOMINAL HYSTERECTOMY; TOTAL LAPAROSCOPIC HYSTERECTOMY; UTERINE TUBE; UTERINE TUBE CARCINOMA;

EID: 84856004219     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.10.017     Document Type: Editorial

References (25)

1. S.M. Domchek, and T.R. Rebbeck Prophylactic oophorectomy in women at increased cancer risk Curr Opin Obstet Gynecol 19 2007 27 30 (Pubitemid 46095869)
2. R. Manchanda, A. Abdelraheim, M. Johnson, A. Rosenthal, E. Benjamin, and C. Brunell Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status BJOG 118 2011 814 824
3. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 2007 3985 3990 (Pubitemid 47477278)
4. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132 (Pubitemid 41702631)
5. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation JAMA 296 2006 185 192
6. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. Van't Veer, and J.E. Garber Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622 (Pubitemid 34755669)
7. K. Haldar, P. Giamougiannis, and R. Crawford Utility of peritoneal lavage cytology during laparoscopic salpingo-oophorectomy: a retrospective analysis BJOG 118 2011 28 33
8. M.L. Carcangiu, P. Radice, S. Manoukian, G. Spatti, M. Gobbo, and V. Pensotti Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers Int J Gynecol Pathol 23 2004 35 40 (Pubitemid 38018235)
9. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 2001 1283 1289 (Pubitemid 32917122)
10. L. Scheuer, N. Kauff, M. Robson, B. Kelly, R. Barakat, and J. Satagopan Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 2002 1260 1268 (Pubitemid 34177432)
11. M.L. Carcangiu, B. Peissel, B. Pasini, G. Spatti, P. Radice, and S. Manoukian Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature Am J Surg Pathol 30 2006 1222 1230 (Pubitemid 44454699)
12. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 2006 58 64 (Pubitemid 41815050)
13. N.D. Kauff, J.M. Satagopan, M.E. Robson, L. Scheuer, M. Hensley, and C.A. Hudis Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 2002 1609 1615 (Pubitemid 34755668)
14. K.H. Lu, J.E. Garber, D.W. Cramer, W.R. Welch, J. Niloff, and D. Schrag Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J Clin Oncol 18 2000 2728 2732 (Pubitemid 30463555)
15. J.T. Rabban, E. Krasik, L.M. Chen, C.B. Powell, B. Crawford, and C.J. Zaloudek Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol Am J Surg Pathol 33 2009 1878 1885
16. H. Salazar, A.K. Godwin, M.B. Daly, P.B. Laub, W.M. Hogan, and N. Rosenblum Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies J Natl Cancer Inst 88 1996 1810 1820 (Pubitemid 26425055)
17. P.W. Schlosshauer, C.J. Cohen, F. Penault-Llorca, C.R. Miranda, Y.J. Bignon, and J. Dauplat Prophylactic oophorectomy: a morphologic and immunohistochemical study Cancer 98 2003 2599 2606 (Pubitemid 37509523)
18. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236 (Pubitemid 43740193)
19. C. Vaysse, C. Touboul, T. Filleron, E. Mery, E. Jouve, and P. Leguevaque Early stage (IA-IB) primary carcinoma of the fallopian tube: case-control comparison to adenocarcinoma of the ovary J Gynecol Oncol 22 2011 9 17
20. S.L. Wethington, T.J. Herzog, V.E. Seshan, N. Bansal, P.B. Schiff, and W.M. Burke Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer Cancer 113 2008 3298 3306
21. D. Pectasides, E. Pectasides, G. Papaxoinis, C. Andreadis, G. Papatsibas, and G. Fountzilas Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients Gynecol Oncol 115 2009 97 101
22. K. Levanon, C. Crum, and R. Drapkin New insights into the pathogenesis of serous ovarian cancer and its clinical impact J Clin Oncol 26 2008 5284 5293
23. Y. Lee, A. Miron, R. Drapkin, M.R. Nucci, F. Medeiros, and A. Saleemuddin A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 2007 26 35 (Pubitemid 46092026)
24. C.P. Crum, R. Drapkin, A. Miron, T.A. Ince, M. Muto, and D.W. Kindelberger The distal fallopian tube: a new model for pelvic serous carcinogenesis Curr Opin Obstet Gynecol 19 2007 3 9 (Pubitemid 46095865)
25. POINT Pelvic-Ovarian Cancer Interception Project In: http://pointproject. org 2010